On the public citation graph

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972

https://doi.org/10.1093/annonc/mdg157
0 signed · 181 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-wopenalex-snapshot
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas
inferredcites →https://doi.org/10.1002/cncr.11187openalex-snapshot
Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features
inferredcites →https://doi.org/10.1002/cncr.20042openalex-snapshot
Second‐line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy
inferredcites →https://doi.org/10.1007/978-1-4612-4380-9_25openalex-snapshot
Nonparametric Estimation from Incomplete Observations
inferredcites →https://doi.org/10.1016/0197-2456(89)90015-9openalex-snapshot
Optimal two-stage designs for phase II clinical trials
inferredcites →https://doi.org/10.1023/a:1008336732273openalex-snapshot
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study
inferredcites →https://doi.org/10.1023/a:1019608404378openalex-snapshot
Salvage Chemotherapy with CPT-11 for Recurrent Oligodendrogliomas
inferredcites →https://doi.org/10.1080/01621459.1958.10501452openalex-snapshot
Nonparametric Estimation from Incomplete Observations
inferredcites →https://doi.org/10.1097/00006123-199811000-00035openalex-snapshot
PCV Chemotherapy for Recurrent Oligodendrogliomas and Oligoastrocytomas
inferredcites →https://doi.org/10.1200/jco.1990.8.7.1277openalex-snapshot
Response criteria for phase II studies of supratentorial malignant glioma.
inferredcites →https://doi.org/10.1200/jco.1994.12.10.2013openalex-snapshot
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
inferredcites →https://doi.org/10.1200/jco.1997.15.12.3427openalex-snapshot
Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas.
inferredcites →https://doi.org/10.1200/jco.1999.17.9.2762openalex-snapshot
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
inferredcites →https://doi.org/10.1200/jco.2001.19.9.2449openalex-snapshot
Safety and Efficacy of Temozolomide in Patients With Recurrent Anaplastic Oligodendrogliomas After Standard Radiotherapy and Chemotherapy
inferredcites →https://doi.org/10.1212/wnl.51.4.1140openalex-snapshot
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy
inferredcites →https://doi.org/10.1212/wnl.53.5.1141openalex-snapshot
Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma
inferredcites →https://doi.org/10.1212/wnl.57.2.340openalex-snapshot
Temozolomide chemotherapy in recurrent oligodendroglioma
inferredcites →https://doi.org/10.3171/jns.1996.85.4.0597openalex-snapshot
Salvage chemotherapy for oligodendroglioma

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4055067openalex-extracted
inferred← citeshttps://doi.org/10.1002/14651858.cd011773.pub2openalex-snapshot
Procarbazine, lomustine and vincristine for recurrent high-grade glioma
inferred← citeshttps://doi.org/10.1002/cncr.20042openalex-snapshot
Second‐line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy
inferred← citeshttps://doi.org/10.1002/pbc.21270openalex-snapshot
Temozolomide in pediatric low‐grade glioma
inferred← citeshttps://doi.org/10.1007/0-387-31056-8_34openalex-snapshot
Central Nervous System Tumors
inferred← citeshttps://doi.org/10.1007/3-540-31260-9_7openalex-snapshot
Oligodendroglioma
inferred← citeshttps://doi.org/10.1007/978-0-387-29202-1_8openalex-snapshot
Cytotoxic Chemotherapy for Diffuse Gliomas
inferred← citeshttps://doi.org/10.1007/978-1-4419-0410-2_2openalex-snapshot
Primary Brain Tumors: Characteristics, Practical Diagnostic and Treatment Approaches
inferred← citeshttps://doi.org/10.1007/978-1-4471-2213-5_25openalex-snapshot
Chemotherapy for Diffuse Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1007/978-1-4471-2213-5_26openalex-snapshot
Radiation Therapy for the Treatment of Diffuse Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1007/978-1-4614-8363-2_19openalex-snapshot
Malignant Glioma: Viewpoint—Chemotherapy
inferred← citeshttps://doi.org/10.1007/978-1-59745-185-7_16openalex-snapshot
Chemotherapy
inferred← citeshttps://doi.org/10.1007/978-1-60761-166-0_10openalex-snapshot
Anaplastic Oligodendrogliomas and Mixed Gliomas
inferred← citeshttps://doi.org/10.1007/978-1-60761-166-0_8openalex-snapshot
Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1007/978-3-030-04152-6_9openalex-snapshot
WHO II and III Gliomas
inferred← citeshttps://doi.org/10.1007/978-3-030-54879-7_22openalex-snapshot
Updates Treatment of Low-Grade Glioma
inferred← citeshttps://doi.org/10.1007/978-3-031-10839-6_10openalex-snapshot
Chemotherapeutic Protocols for the Treatment of Neurological Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-55466-2_25openalex-snapshot
Chemotherapy for Diffuse Low Grade Gliomas
inferred← citeshttps://doi.org/10.1007/978-3-642-00475-9_16openalex-snapshot
Treatment of High-Grade Gliomas in Adults
inferred← citeshttps://doi.org/10.1007/978-3-642-02874-8_8openalex-snapshot
Oligodendroglioma
inferred← citeshttps://doi.org/10.1007/978-90-481-9704-0_4openalex-snapshot
Alkylating Agents
inferred← citeshttps://doi.org/10.1007/s00066-004-1221-6openalex-snapshot
Immediate Postoperative Radiotherapy or “Watch and Wait” in the Management of Adult Low-Grade Glioma?
inferred← citeshttps://doi.org/10.1007/s00066-005-1314-xopenalex-snapshot
Efficacy and Toxicity of Postoperative Temozolomide Radiochemotherapy in Malignant Glioma
inferred← citeshttps://doi.org/10.1007/s00401-007-0293-7openalex-snapshot
Diffuse glioma growth: a guerilla war
inferred← citeshttps://doi.org/10.1007/s00761-006-1068-9openalex-snapshot
Anaplastische Gliome
inferred← citeshttps://doi.org/10.1007/s10014-023-00455-8openalex-snapshot
Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution
inferred← citeshttps://doi.org/10.1007/s11060-004-2028-0openalex-snapshot
Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma
inferred← citeshttps://doi.org/10.1007/s11060-004-2029-zopenalex-snapshot
Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation
inferred← citeshttps://doi.org/10.1007/s11060-004-2748-1openalex-snapshot
Molecular pathogenesis of oligodendroglial tumors
inferred← citeshttps://doi.org/10.1007/s11060-005-9020-1openalex-snapshot
Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial
inferred← citeshttps://doi.org/10.1007/s11060-006-9144-yopenalex-snapshot
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors
inferred← citeshttps://doi.org/10.1007/s11060-007-9422-3openalex-snapshot
Role of exclusive chemotherapy as first line treatment in oligodendroglioma
inferred← citeshttps://doi.org/10.1007/s11060-011-0657-7openalex-snapshot
Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity
inferred← citeshttps://doi.org/10.1007/s11060-012-0832-5openalex-snapshot
Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
inferred← citeshttps://doi.org/10.1007/s11060-013-1288-yopenalex-snapshot
Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers
inferred← citeshttps://doi.org/10.1007/s11060-014-1495-1openalex-snapshot
Medical therapy of gliomas
inferred← citeshttps://doi.org/10.1007/s11060-015-1902-2openalex-snapshot
A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13–12
inferred← citeshttps://doi.org/10.1007/s11060-015-1910-2openalex-snapshot
Management of patients with recurrence of diffuse low grade glioma
inferred← citeshttps://doi.org/10.1007/s11060-015-1949-0openalex-snapshot
Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey
inferred← citeshttps://doi.org/10.1007/s11060-017-2443-7openalex-snapshot
Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma
inferred← citeshttps://doi.org/10.1007/s11864-009-0091-7openalex-snapshot
The Role of Chemotherapy for Pure and Mixed Anaplastic Oligodendroglial Tumors
inferred← citeshttps://doi.org/10.1007/s11864-009-0096-2openalex-snapshot
Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1007/s11910-004-0042-4openalex-snapshot
Malignant gliomas
inferred← citeshttps://doi.org/10.1007/s11910-005-0047-7openalex-snapshot
Optimal role of temozolomide in the treatment of malignant gliomas
inferred← citeshttps://doi.org/10.1007/s11910-006-0008-9openalex-snapshot
Recent advances in the treatment of oligodendrogliomas
inferred← citeshttps://doi.org/10.1007/s11940-005-0040-0openalex-snapshot
Oligodendroglioma
inferred← citeshttps://doi.org/10.1007/s11940-008-0032-yopenalex-snapshot
Anaplastic oligodendroglioma
inferred← citeshttps://doi.org/10.1007/s11940-010-0078-5openalex-snapshot
Recurrent High-Grade Glioma
inferred← citeshttps://doi.org/10.1007/s11940-012-0177-6openalex-snapshot
Anaplastic Glioma
inferred← citeshttps://doi.org/10.1007/s40263-014-0215-xopenalex-snapshot
Pharmacologic Therapies for Malignant Glioma: A Guide for Clinicians
inferred← citeshttps://doi.org/10.1016/b978-0-12-812100-9.00034-6openalex-snapshot
Chemotherapy of Oligodendrogliomas
inferred← citeshttps://doi.org/10.1016/b978-0-12-813158-9.00023-2openalex-snapshot
Stereotactic radiosurgery in the management of oligodendroglioma
inferred← citeshttps://doi.org/10.1016/b978-0-12-813158-9.00029-3openalex-snapshot
Temozolomide chemotherapy for oligodendroglial tumors
inferred← citeshttps://doi.org/10.1016/b978-0-12-813158-9.00032-3openalex-snapshot
Bevacizumab for recurrent anaplastic oligodendroglial tumors
inferred← citeshttps://doi.org/10.1016/b978-0-323-24098-7.00026-5openalex-snapshot
Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1016/b978-0-323-47674-4.00063-3openalex-snapshot
Cancer of the Central Nervous System
inferred← citeshttps://doi.org/10.1016/b978-0-443-06694-8.50074-9openalex-snapshot
Cancer of the Central Nervous System
inferred← citeshttps://doi.org/10.1016/b978-0-443-27356-8.00073-5openalex-snapshot
Chemotherapy of oligodendrogliomas
inferred← citeshttps://doi.org/10.1016/b978-0-444-52138-5.00017-7openalex-snapshot
Chemotherapy with cytotoxic and cytostatic agents in brain cancer
inferred← citeshttps://doi.org/10.1016/b978-012088410-0/50064-0openalex-snapshot
Chemotherapy of Oligodendrogliomas
inferred← citeshttps://doi.org/10.1016/b978-012088410-0/50065-2openalex-snapshot
Chemotherapy of Oligoastrocytomas
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3431-5.00017-0openalex-snapshot
Tumors of the Brain and Spinal Cord
inferred← citeshttps://doi.org/10.1016/b978-1-4557-2865-7.00066-7openalex-snapshot
Cancer of the Central Nervous System
inferred← citeshttps://doi.org/10.1016/b978-1-4557-5414-4.00057-7openalex-snapshot
10.1016/b978-1-4557-5414-4.00057-7
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2022.121813openalex-snapshot
Modulating Cancer-Stroma Crosstalk by a Nanoparticle-Based Photodynamic Method to Pave the Way for Subsequent Therapies
inferred← citeshttps://doi.org/10.1016/j.canlet.2005.11.029openalex-snapshot
Skin delivery potency and antitumor activities of temozolomide ester prodrugs
inferred← citeshttps://doi.org/10.1016/j.clon.2014.04.001openalex-snapshot
Current Concepts in the Surgical Management of Glioma Patients
inferred← citeshttps://doi.org/10.1016/j.ejca.2005.06.031openalex-snapshot
Recent developments in the use of chemotherapy in brain tumours
inferred← citeshttps://doi.org/10.1016/j.ejca.2006.05.021openalex-snapshot
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
inferred← citeshttps://doi.org/10.1016/j.ejca.2024.114034openalex-snapshot
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas
inferred← citeshttps://doi.org/10.1016/j.hoc.2006.09.003openalex-snapshot
The Changing Management of Low-Grade Astrocytomas and Oligodendrogliomas
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2014.11.012openalex-snapshot
Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424
inferred← citeshttps://doi.org/10.1016/j.jocn.2004.10.018openalex-snapshot
Phase II study of two-weekly temozolomide in patients with high-grade gliomas
inferred← citeshttps://doi.org/10.1016/j.ncl.2007.07.007openalex-snapshot
Management of Patients with Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1016/j.ncl.2018.04.005openalex-snapshot
Grade II and III Oligodendroglioma and Astrocytoma
inferred← citeshttps://doi.org/10.1016/j.neucir.2011.07.001openalex-snapshot
Gliomas hemisféricos OMS grado II: revisión del manejo actual
inferred← citeshttps://doi.org/10.1016/j.neurol.2011.08.006openalex-snapshot
Chemotherapy for diffuse low-grade gliomas in adults
inferred← citeshttps://doi.org/10.1016/j.neurol.2023.03.001openalex-snapshot
Thirty years of progress in the management of low-grade gliomas
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2008.11.003openalex-snapshot
Pharmacotherapy for adults with tumors of the central nervous system
inferred← citeshttps://doi.org/10.1016/j.radonc.2008.03.005openalex-snapshot
Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors
inferred← citeshttps://doi.org/10.1016/j.semradonc.2015.02.008openalex-snapshot
Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?
inferred← citeshttps://doi.org/10.1016/j.uct.2006.06.005openalex-snapshot
Central nervous system tumors
inferred← citeshttps://doi.org/10.1016/s0028-3770(05)83497-6openalex-snapshot
Place de la chimiothérapie et de la radiothérapie dans le traitement des oligodendrogliomes
inferred← citeshttps://doi.org/10.1016/s0140-6736(18)30990-5openalex-snapshot
Primary brain tumours in adults
inferred← citeshttps://doi.org/10.1016/s0921-4410(03)21008-5openalex-snapshot
DNA-binding agents
inferred← citeshttps://doi.org/10.1016/s0921-4410(04)22008-7openalex-snapshot
DNA-binding agents
inferred← citeshttps://doi.org/10.1016/s0959-8049(01)00451-8openalex-snapshot
EORTC Brain Tumor Group
inferred← citeshttps://doi.org/10.1016/s1474-4422(05)70222-2openalex-snapshot
Low-grade gliomas: an update on pathology and therapy
inferred← citeshttps://doi.org/10.1021/acs.nanolett.1c02803openalex-snapshot
Circumventing Drug Resistance Pathways with a Nanoparticle-Based Photodynamic Method
inferred← citeshttps://doi.org/10.1023/b:neon.0000040837.68411.97openalex-snapshot
Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas
inferred← citeshttps://doi.org/10.1039/c4ay01641fopenalex-snapshot
Simultaneous determination of temozolomide acid and its hexyl ester in plasma by LC-MS/MS: application to the first pharmacokinetic study of temozolomide hexyl ester in rats
inferred← citeshttps://doi.org/10.1039/d5nj01660fopenalex-snapshot
CTF-1 triazine framework as a drug delivery surface for the anticancer drugs carmustine and temozolomide: a DFT study
inferred← citeshttps://doi.org/10.1042/bsr20180005openalex-snapshot
Carnosic acid impedes cell growth and enhances anticancer effects of carmustine and lomustine in melanoma
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2003.11.022openalex-snapshot
The European organisation for research and treatment of cancer strategy for new drug development in brain tumors
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2003.11.028openalex-snapshot
State-of-the-art treatment of high-grade brain tumors
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2004.07.006openalex-snapshot
Diagnosis and management of oligodendroglioma
inferred← citeshttps://doi.org/10.1080/07357900701509403openalex-snapshot
Temozolomide and Radiation in Low-Grade and Anaplastic Gliomas: Temoradiation
inferred← citeshttps://doi.org/10.1089/1043034041648417openalex-snapshot
Lentivirus-Mediated Expression of Mutant MGMT P140K Protects Human CD34 + Cells Against the Combined Toxicity of O 6 -Benzylguanine and 1,3-Bis(2-Chloroethyl)-Nitrosourea or Temozolomide
inferred← citeshttps://doi.org/10.1093/annonc/mdg502openalex-snapshot
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response
inferred← citeshttps://doi.org/10.1093/annonc/mdh003openalex-snapshot
Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors
inferred← citeshttps://doi.org/10.1093/annonc/mdn434openalex-snapshot
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy
inferred← citeshttps://doi.org/10.1093/neuonc/5.2.128openalex-snapshot
Recent developments in the molecular characterization and treatment of oligodendroglial tumors
inferred← citeshttps://doi.org/10.1093/neuonc/nos092openalex-snapshot
LOW GRADE GLIOMAS
inferred← citeshttps://doi.org/10.1093/neuonc/nou297openalex-snapshot
Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma
inferred← citeshttps://doi.org/10.1093/neuonc/noz033openalex-snapshot
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus
inferred← citeshttps://doi.org/10.1093/noajnl/vdae078openalex-snapshot
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network
inferred← citeshttps://doi.org/10.1097/00019052-200412000-00006openalex-snapshot
Advances in the biology and treatment of oligodendrogliomas
inferred← citeshttps://doi.org/10.1097/01.jnen.0000263869.84188.72openalex-snapshot
Panel Review of Anaplastic Oligodendroglioma From European Organization for Research and Treatment of Cancer Trial 26951
inferred← citeshttps://doi.org/10.1097/01.nrl.0000250928.26044.47openalex-snapshot
Glioma Therapy in Adults
inferred← citeshttps://doi.org/10.1097/01.wco.0000189877.31637.74openalex-snapshot
An update on oligodendroglial neoplasms
inferred← citeshttps://doi.org/10.1097/cco.0b013e3282f0313bopenalex-snapshot
Molecular targeted therapies and chemotherapy in malignant gliomas
inferred← citeshttps://doi.org/10.1097/cco.0b013e328357f503openalex-snapshot
Chemotherapy in low-grade gliomas
inferred← citeshttps://doi.org/10.1097/nen.0b013e31815c254dopenalex-snapshot
Intratumoral Distribution of 1p Loss in Oligodendroglial Tumors
inferred← citeshttps://doi.org/10.1097/ppo.0b013e31818d8178openalex-snapshot
Gliomas With 1p/19q Codeletion:a.k.a. Oligodendroglioma
inferred← citeshttps://doi.org/10.1111/j.1468-1331.2007.01675.xopenalex-snapshot
Treatment of newly diagnosed symptomatic pure low‐grade oligodendrogliomas with PCV chemotherapy
inferred← citeshttps://doi.org/10.1111/j.1468-1331.2012.03778.xopenalex-snapshot
The efficacy of temozolomide for recurrent glioblastoma multiforme
inferred← citeshttps://doi.org/10.1111/j.1600-0447.1951.tb08185.xopenalex-snapshot
DIAGNOSIS AND PROGNOSIS
inferred← citeshttps://doi.org/10.1111/j.1750-3639.2004.tb00083.xopenalex-snapshot
Galectin‐3 as an Immunohistochemical Tool to Distinguish Pilocytic Astrocytomas from Diffuse Astrocytomas, and Glioblastomas from Anaplastic Oligodendrogliomas
inferred← citeshttps://doi.org/10.1111/neup.12406openalex-snapshot
Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted
inferred← citeshttps://doi.org/10.1148/rg.256055137openalex-snapshot
Oligodendroglioma and Its Variants: Radiologic-Pathologic Correlation
inferred← citeshttps://doi.org/10.1177/030089160909500308openalex-snapshot
Long-Term Outcome of Postoperative Irradiation in Patients with Newly Diagnosed WHO Grade III Anaplastic Gliomas
inferred← citeshttps://doi.org/10.1200/jco.2003.12.015openalex-snapshot
Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971
inferred← citeshttps://doi.org/10.1200/jco.2005.04.9874openalex-snapshot
Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of Response
inferred← citeshttps://doi.org/10.1200/jco.2005.05.2399openalex-snapshot
Diffusely Infiltrative Low-Grade Gliomas in Adults
inferred← citeshttps://doi.org/10.1212/01.wnl.0000137049.65631.dbopenalex-snapshot
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas
inferred← citeshttps://doi.org/10.1212/01.wnl.0000319721.98502.1bopenalex-snapshot
Invited Article: The expanding impact of molecular biology on the diagnosis and treatment of gliomas
inferred← citeshttps://doi.org/10.1212/wnl.0b013e3181a413beopenalex-snapshot
Bevacizumab and irinotecan for recurrent oligodendroglial tumors
inferred← citeshttps://doi.org/10.1215/15228517-2007-002openalex-snapshot
Survey of treatment recommendations for anaplastic oligodendroglioma
inferred← citeshttps://doi.org/10.14791/btrt.2025.0010openalex-snapshot
Long-Term Remission of Recurrent Anaplastic Oligodendroglioma With WT-1-Specific CD8+ T-Cell Therapy: A Case Report
inferred← citeshttps://doi.org/10.1517/14656566.5.2.295openalex-snapshot
Chemotherapy of anaplastic oligodendroglial tumours
inferred← citeshttps://doi.org/10.1517/14656566.7.6.749openalex-snapshot
Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future
inferred← citeshttps://doi.org/10.1517/14728214.13.1.81openalex-snapshot
Emerging drugs for malignant glioma
inferred← citeshttps://doi.org/10.1586/14737140.3.5.655openalex-snapshot
Update on the therapeutic approaches to brain tumors
inferred← citeshttps://doi.org/10.1586/14737140.4.5.759openalex-snapshot
Therapy for recurrent malignant glioma in adults
inferred← citeshttps://doi.org/10.1586/14737140.6.5.755openalex-snapshot
Chemotherapy in the treatment of malignant gliomas
inferred← citeshttps://doi.org/10.1586/14737140.6.8.1187openalex-snapshot
Temozolomide: a milestone in neuro-oncology and beyond?
inferred← citeshttps://doi.org/10.1586/14737140.7.12s.s15openalex-snapshot
Low-grade gliomas: management issues
inferred← citeshttps://doi.org/10.1586/14737175.2015.1042455openalex-snapshot
Anaplastic glioma: current treatment and management
inferred← citeshttps://doi.org/10.1586/14737175.8.10.1475openalex-snapshot
Epigenetic markers in human gliomas: prospects for therapeutic intervention
inferred← citeshttps://doi.org/10.1586/ern.10.32openalex-snapshot
Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
inferred← citeshttps://doi.org/10.1634/theoncologist.11-2-165openalex-snapshot
Changing Paradigms—An Update on the Multidisciplinary Management of Malignant Glioma
inferred← citeshttps://doi.org/10.1634/theoncologist.2008-0248openalex-snapshot
Oligodendrogliomas: Molecular Biology and Treatment
inferred← citeshttps://doi.org/10.1684/bdc.2009.0865openalex-snapshot
Guide de prescription et de bon usage du témozolomide dans les tumeurs cérébrales
inferred← citeshttps://doi.org/10.17116/onkolog20154683-89openalex-snapshot
Prognostic factors for low-grade diffuse gliomas and approaches to their treatment
inferred← citeshttps://doi.org/10.17116/onkolog20211004136openalex-snapshot
Treatment for recurrent low-grade gliomas
inferred← citeshttps://doi.org/10.2147/cmar.s54726openalex-snapshot
Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods
inferred← citeshttps://doi.org/10.2147/ott.s108989openalex-snapshot
Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection
inferred← citeshttps://doi.org/10.2176/nmc.ra.2017-0071openalex-snapshot
Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016
inferred← citeshttps://doi.org/10.2217/14796694.1.6.747openalex-snapshot
Temozolomide: A Milestone In the Pharmacotherapy of Brain Tumors
inferred← citeshttps://doi.org/10.2217/cns.12.26openalex-snapshot
Surgical management of high-grade glioma: a standard of care
inferred← citeshttps://doi.org/10.2217/cns.15.2openalex-snapshot
Chemotherapy in glioma
inferred← citeshttps://doi.org/10.3171/2011.4.jns11521openalex-snapshot
Editorial: Low-grade gliomas
inferred← citeshttps://doi.org/10.3171/foc.2006.20.4.3openalex-snapshot
Management of malignant glioma: steady progress with multimodal approaches
inferred← citeshttps://doi.org/10.3340/jkns.2013.54.6.489openalex-snapshot
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
inferred← citeshttps://doi.org/10.3747/co.2007.119openalex-snapshot
Canadian Recommendations for the Treatment of Glioblastoma Multiforme
inferred← citeshttps://doi.org/10.38207/jmcrcs/2022/aug03080562openalex-snapshot
Oligosarcoma Arising from Oligodendroglioma-A case report
inferred← citeshttps://doi.org/10.3892/ol.2012.759openalex-snapshot
Response to postoperative radiotherapy as a prognostic factor for patients with low-grade gliomas
inferred← citeshttps://doi.org/10.4065/82.10.1271openalex-snapshot
Central Nervous System Tumors
inferred← citeshttps://doi.org/10.4103/0019-509x.49148openalex-snapshot
Current concepts in the pathology and genetics of gliomas
inferred← citeshttps://doi.org/10.4103/2152-7806.151331openalex-snapshot
The future of high-grade glioma: Where we are and where are we going
inferred← citeshttps://doi.org/10.47102/annals-acadmedsg.v36n5p364openalex-snapshot
Chemotherapy in Adults with Gliomas
inferred← citeshttps://doi.org/10.5402/2012/530179openalex-snapshot
Resection and Immunotherapy for Recurrent Grade III Glioma
inferred← citeshttps://doi.org/10.7759/cureus.51161openalex-snapshot
Global and Gender Equity in Oligodendroglioma Research: A Comprehensive Bibliometric Analysis Following the COVID-19 Pandemic
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.